These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38627970)

  • 1. A structure-based computational model of IP
    Greene D; Shiferaw Y
    Biophys J; 2024 May; 123(10):1274-1288. PubMed ID: 38627970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand sensitivity of type-1 inositol 1,4,5-trisphosphate receptor is enhanced by the D2594K mutation.
    Tambeaux A; Aguilar-Sánchez Y; Santiago DJ; Mascitti M; DiNovo KM; Mejía-Alvarez R; Fill M; Wayne Chen SR; Ramos-Franco J
    Pflugers Arch; 2023 May; 475(5):569-581. PubMed ID: 36881190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release.
    Alzayady KJ; Wang L; Chandrasekhar R; Wagner LE; Van Petegem F; Yule DI
    Sci Signal; 2016 Apr; 9(422):ra35. PubMed ID: 27048566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IP3 receptors: Take four IP3 to open.
    Taylor CW; Konieczny V
    Sci Signal; 2016 Apr; 9(422):pe1. PubMed ID: 27048564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant IP
    Ando H; Hirose M; Mikoshiba K
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12259-12264. PubMed ID: 30429331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and IP
    Ivanova H; Wagner LE; Tanimura A; Vandermarliere E; Luyten T; Welkenhuyzen K; Alzayady KJ; Wang L; Hamada K; Mikoshiba K; De Smedt H; Martens L; Yule DI; Parys JB; Bultynck G
    Cell Mol Life Sci; 2019 Oct; 76(19):3843-3859. PubMed ID: 30989245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational motions and ligand-binding underlying gating and regulation in IP
    Fan G; Baker MR; Terry LE; Arige V; Chen M; Seryshev AB; Baker ML; Ludtke SJ; Yule DI; Serysheva II
    Nat Commun; 2022 Nov; 13(1):6942. PubMed ID: 36376291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IP
    Hamada K; Miyatake H; Terauchi A; Mikoshiba K
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4661-4666. PubMed ID: 28416699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol 1,4,5-trisphosphate activates TRPC3 channels to cause extracellular Ca2+ influx in airway smooth muscle cells.
    Song T; Hao Q; Zheng YM; Liu QH; Wang YX
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1455-66. PubMed ID: 26453517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the regulation of inositol trisphosphate receptors by Ca
    Paknejad N; Hite RK
    Nat Struct Mol Biol; 2018 Aug; 25(8):660-668. PubMed ID: 30013099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.
    Alzayady KJ; Wagner LE; Chandrasekhar R; Monteagudo A; Godiska R; Tall GG; Joseph SK; Yule DI
    J Biol Chem; 2013 Oct; 288(41):29772-84. PubMed ID: 23955339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional rearrangements within inositol 1,4,5-trisphosphate receptor by calcium.
    Hamada K; Terauchi A; Mikoshiba K
    J Biol Chem; 2003 Dec; 278(52):52881-9. PubMed ID: 14593123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-specific proteolysis differentially regulates type 1 inositol 1,4,5-trisphosphate receptor activity.
    Wang L; Wagner LE; Alzayady KJ; Yule DI
    J Biol Chem; 2017 Jul; 292(28):11714-11726. PubMed ID: 28526746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic model of single and clustered IP3 receptors in the absence of Ca2+ feedback.
    Shuai J; Pearson JE; Foskett JK; Mak DO; Parker I
    Biophys J; 2007 Aug; 93(4):1151-62. PubMed ID: 17526578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
    Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
    J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and dynamic insights into the subtype-specific IP3-binding mechanism of the IP3 receptor.
    Lee SY; Yoo HS; Choi HS; Chung KY; Seo MD
    Biochem J; 2016 Oct; 473(20):3533-3543. PubMed ID: 27444647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Ca2+ in triggering inositol 1,4,5-trisphosphate receptor ubiquitination.
    Alzayady KJ; Wojcikiewicz RJ
    Biochem J; 2005 Dec; 392(Pt 3):601-6. PubMed ID: 16134970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsinized cerebellar inositol 1,4,5-trisphosphate receptor. Structural and functional coupling of cleaved ligand binding and channel domains.
    Yoshikawa F; Iwasaki H; Michikawa T; Furuichi T; Mikoshiba K
    J Biol Chem; 1999 Jan; 274(1):316-27. PubMed ID: 9867846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of inositol 1,4,5-trisphosphate (IP
    Chandran A; Chee X; Prole DL; Rahman T
    Sci Rep; 2019 Feb; 9(1):2454. PubMed ID: 30792485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional determination of calcium-binding sites required for the activation of inositol 1,4,5-trisphosphate receptors.
    Arige V; Terry LE; Wagner LE; Malik S; Baker MR; Fan G; Joseph SK; Serysheva II; Yule DI
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2209267119. PubMed ID: 36122240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.